Unaudited Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit
Balance at beginning (in shares) at Dec. 31, 2023	130,648,426
Balance at beginning at Dec. 31, 2023	$ 162,147
Balance at ending (in shares) at Mar. 31, 2024	130,648,426
Balance at ending at Mar. 31, 2024	$ 162,147
Balance at beginning (in shares) at Dec. 31, 2023		460,704
Balance at beginning at Dec. 31, 2023	(123,730)	$ 1	$ 36,231	$ (159,962)
Changes in Stockholders' Deficit
Stock option exercises (in shares)		971
Stock option exercises	2		2
Vesting of restricted common stock (in shares)		14,589
Stock-based compensation expense	856		856
Net loss	(12,456)			(12,456)
Balance at ending (in shares) at Mar. 31, 2024		476,264
Balance at ending at Mar. 31, 2024	$ (135,328)	$ 1	37,089	(172,418)
Balance at beginning (in shares) at Dec. 31, 2023	130,648,426
Balance at beginning at Dec. 31, 2023	$ 162,147
Balance at ending (in shares) at Sep. 30, 2024	130,648,426
Balance at ending at Sep. 30, 2024	$ 162,147
Balance at beginning (in shares) at Dec. 31, 2023		460,704
Balance at beginning at Dec. 31, 2023	(123,730)	$ 1	36,231	(159,962)
Changes in Stockholders' Deficit
Net loss	(38,512)
Balance at ending (in shares) at Sep. 30, 2024		1,005,930
Balance at ending at Sep. 30, 2024	$ (158,975)	$ 2	39,497	(198,474)
Balance at beginning (in shares) at Mar. 31, 2024	130,648,426
Balance at beginning at Mar. 31, 2024	$ 162,147
Balance at ending (in shares) at Jun. 30, 2024	130,648,426
Balance at ending at Jun. 30, 2024	$ 162,147
Balance at beginning (in shares) at Mar. 31, 2024		476,264
Balance at beginning at Mar. 31, 2024	(135,328)	$ 1	37,089	(172,418)
Changes in Stockholders' Deficit
Issuance of common stock, net of issuance costs (in shares)		88
Vesting of restricted common stock (in shares)		14,525
Stock-based compensation expense	786		786
Net loss	(12,572)			(12,572)
Balance at ending (in shares) at Jun. 30, 2024		490,877
Balance at ending at Jun. 30, 2024	$ (147,114)	$ 1	37,875	(184,990)
Balance at ending (in shares) at Sep. 30, 2024	130,648,426
Balance at ending at Sep. 30, 2024	$ 162,147
Changes in Stockholders' Deficit
Stock option exercises (in shares)		500,531
Stock option exercises	31	$ 1	30
Vesting of restricted common stock (in shares)		14,522
Stock-based compensation expense	1,592		1,592
Net loss	(13,484)			(13,484)
Balance at ending (in shares) at Sep. 30, 2024		1,005,930
Balance at ending at Sep. 30, 2024	$ (158,975)	$ 2	39,497	(198,474)
Balance at beginning (in shares) at Dec. 31, 2024	20,145,129	20,145,129
Balance at beginning at Dec. 31, 2024	$ 63,144	$ 2	274,895	(211,753)
Changes in Stockholders' Deficit
Stock option exercises (in shares)		1
Vesting of restricted common stock (in shares)		11,666
Stock-based compensation expense	861		861
Net loss	(12,433)			(12,433)
Balance at ending (in shares) at Mar. 31, 2025		20,156,796
Balance at ending at Mar. 31, 2025	$ 51,572	$ 2	275,756	(224,186)
Balance at beginning (in shares) at Dec. 31, 2024	20,145,129	20,145,129
Balance at beginning at Dec. 31, 2024	$ 63,144	$ 2	274,895	(211,753)
Changes in Stockholders' Deficit
Stock option exercises (in shares)	1,699
Net loss	$ (40,119)
Balance at ending (in shares) at Sep. 30, 2025	46,880,185	46,880,185
Balance at ending at Sep. 30, 2025	$ 58,667	$ 5	310,534	(251,872)
Balance at beginning (in shares) at Mar. 31, 2025		20,156,796
Balance at beginning at Mar. 31, 2025	51,572	$ 2	275,756	(224,186)
Changes in Stockholders' Deficit
Vesting of restricted common stock (in shares)		4,277
Stock-based compensation expense	1,002		1,002
Net loss	(12,587)			(12,587)
Balance at ending (in shares) at Jun. 30, 2025		20,161,073
Balance at ending at Jun. 30, 2025	39,987	$ 2	276,758	(236,773)
Changes in Stockholders' Deficit
Issuance of common stock, net of issuance costs (in shares)		26,717,414
Issuance of common stock, net of issuance costs	29,191	$ 3	29,188
Issuance of pre-funded warrants, net of issuance costs	3,601		3,601
Stock option exercises (in shares)		1,698
Stock option exercises	3		3
Stock-based compensation expense	984		984
Net loss	$ (15,099)			(15,099)
Balance at ending (in shares) at Sep. 30, 2025	46,880,185	46,880,185
Balance at ending at Sep. 30, 2025	$ 58,667	$ 5	$ 310,534	$ (251,872)